Diffuse infantile hepatic hemangiomas: A report of four cases successfully managed with medical therapy

Pediatric Dermatology

Volumn 28, Issue 3, 2011, Pages 267-275

  Yeh, Iwei ^a   Bruckner, Anna L ^b   Sanchez, Rosa ^c   Jeng, Michael R ^b   Newell, Brandon D ^d   Frieden, Ilona J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMLODIPINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; LIOTHYRONINE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; PROPRANOLOL; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERFERON; SPIRONOLACTONE; STEROID; THYROXINE; VINBLASTINE; VINCRISTINE;

ABDOMINAL DISTENSION; ADD ON THERAPY; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CAPILLARY HEMANGIOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSE INFANTILE HEPATIC HEMANGIOMA; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FEVER; GOITER; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; INFANT; JAUNDICE; LABORATORY TEST; LIVER HEMANGIOMA; LIVER TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SEPSIS; SKIN HEMANGIOMA; THYROID FUNCTION TEST; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG THERAPY, COMBINATION; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; PROPRANOLOL; SKIN NEOPLASMS; STEROIDS; THERAPEUTICS; VASODILATOR AGENTS; VINCRISTINE;

EID: 79958047239     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01421.x     Document Type: Article

References (33)

1. Kilcline C, Frieden IJ,. Infantile hemangiomas: how common are they? A systematic review of the medical literature Pediatr Dermatol 2008; 25: 168-173. (Pubitemid 351579596)
2. North PE, Waner M, Mizeracki A, et al., GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11-22. (Pubitemid 30054381)
3. Isaacs H Jr,. Fetal and neonatal hepatic tumors. J Pediatr Surg 2007; 42: 1797-1803. (Pubitemid 350090027)
4. Mo JQ, Dimashkieh HH, Bove KE,. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004; 35: 200-209. (Pubitemid 38240903)
5. Christison-Lagay ER, Burrows PE, Alomari A, et al., Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007; 42: 62-67. discussion 67-8.
6. Zenzen W, Perez-Atayde AR, Elisofon SA, et al., Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol 2009; 39: 1118-1123.
7. Huang SA, Tu HM, Harney JW, et al., Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343: 185-189. (Pubitemid 30489216)
8. Frieden IJ, Rogers M, Garzon MC,. Conditions masquerading as infantile haemangioma: Part 1. Australas J Dermatol 2009; 50: 77-97; quiz 98.
9. Boon LM, Burrows PE, Paltiel HJ, et al., Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129: 346-354. (Pubitemid 27484139)
10. Kassarjian A, Zurakowski D, Dubois J, et al., Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 2004; 182: 785-795. (Pubitemid 38269546)
11. Kalpatthi R, Germak J, Mizelle K, et al., Thyroid abnormalities in infantile hepatic hemangioendothelioma. Pediatr Blood Cancer 2007; 49: 1021-1024. (Pubitemid 350022470)
12. Lee TC, Barshes NR, Agee EE, et al., Resolution of medically resistant hypothyroidism after liver transplantation for hepatic hemangioendothelioma. J Pediatr Surg 2006; 41: 1783-1785. (Pubitemid 44441367)
13. Sovinz P, Urban C, Hausegger K,. Life-threatening hemangiomatosis of the liver in an infant: multimodal therapy including cyclophosphamide and secondary acute myeloid leukemia. Pediatr Blood Cancer 2006; 47: 972-973. (Pubitemid 44656126)
14. Wananukul S, Voramethkul W, Nuchprayoon I, et al., Diffuse neonatal hemangiomatosis: report of 5 cases. J Med Assoc Thai 2006; 89: 1297-1303. (Pubitemid 44358731)
15. Cho YH, Taplin C, Mansour A, et al., Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas. Curr Opin Pediatr 2008; 20: 213-215. (Pubitemid 351365713)
16. Draper H, Diamond IR, Temple M, et al., Multimodal management of endangering hepatic hemangioma: impact on transplant avoidance: a descriptive case series. J Pediatr Surg 2008; 43: 120-125. discussion 126.
17. Dickie B, Dasgupta R, Nair R, et al., Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44: 125-133.
18. Mouat F, Evans HM, Cutfield WS, et al., Massive hepatic hemangioendothelioma and consumptive hypothyroidism. J Pediatr Endocrinol Metab 2008; 21: 701-703.
19. Dong KR, Zheng S, Xiao X,. Conservative management of neonatal hepatic hemangioma: a report from one institute. Pediatr Surg Int 2009; 25: 493-498.
20. Marsciani A, Pericoli R, Alaggio R, et al., Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010; 54: 176.
21. Bessho K, Etani Y, Ichimori H, et al., Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 2010; 169: 215-221.
22. van der Meijs BB, Merks JH, de Haan TR, et al., Neonatal hepatic haemangioendothelioma: treatment options and dilemmas. Pediatr Radiol 2009; 39: 277-281.
23. Al-Tonbary Y, Fouda A,. Infantile hepatic hemangioendothelioma: an 8-month old infant successfully treated with a corticosteroid. Hematol Oncol Stem Cell Ther 2009; 2: 422-425.
24. Kassarjian A, Dubois J, Burrows PE,. Angiographic classification of hepatic hemangiomas in infants. Radiology 2002; 222: 693-698. (Pubitemid 34215216)
25. Ayling RM, Davenport M, Hadzic N, et al., Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 2001; 138: 932-935. (Pubitemid 32545605)
26. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al., Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010; 157: 340-342.
27. Barlow CF, Priebe CJ, Mulliken JB, et al., Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998; 132: 527-530. (Pubitemid 28180264)
28. Stanley P, Geer GD, Miller JH, et al., Infantile hepatic hemangiomas. Clinical features, radiologic investigations, and treatment of 20 patients. Cancer 1989; 64: 936-949. (Pubitemid 19188838)
29. Hurvitz SA, Hurvitz CH, Sloninsky L, et al., Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000; 22: 527-532. (Pubitemid 33599828)
30. Gottschling S, Schneider G, Meyer S, et al., Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 2006; 46: 239-242. (Pubitemid 43076076)
31. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651. (Pubitemid 351831393)
32. Sans V, Dumas de la Roque E, Berge J, et al., Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-e431.
33. Holland KE, Frieden IJ, Frommelt PC, et al., Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775-778.